Black cohosh
EMA traditional herbal medicine for menopausal complaints; the Cochrane review found no significant reduction in hot flushes versus placebo, and there is a reported hepatotoxicity concern.
- Evidence
- Preliminary evidenceGRADE certainty: Low
- Typical dose
- Standardised extracts used in trials: an isopropanolic extract at 40 mg/day, or an ethanolic extract at 6.5 mg/day
- Time to effect
- Not established
- Safety
- Has documented cautions
Evidence ratings summarise published research on Black cohosh in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.
Ask about Black cohosh
Interactions
Taking any medication?
Check Black cohosh against it.
Why
Black cohosh (Cimicifuga racemosa, syn. Actaea racemosa) is registered by the EMA as a traditional herbal medicine for menopausal complaints such as hot flushes and excessive sweating, based on long-standing use rather than trials. A Cochrane review of 16 RCTs (n=2,027 women) found no significant reduction in hot flush frequency versus placebo. NICE (NG23) notes some evidence of symptom relief but uncertain safety and variable preparations, and NICE (NG101) advises against its use in women with breast cancer.
How it works
Originally thought to be oestrogenic, now better understood as having dopaminergic and serotonergic central activity that may modulate the thermoregulatory threshold disturbance underlying hot flushes.
Expected onset · Not established; the Cochrane review found no significant reduction in hot flush frequency
How to take
Dosage
Standardised extracts used in trials: an isopropanolic extract at 40 mg/day, or an ethanolic extract (BNO 1055) at 6.5 mg/day. Higher doses up to 160 mg/day have been used.
Timing
Once or twice daily with food
On the label
Look for a standardised extract with the extract type (isopropanolic or ethanolic) and milligrams stated.
Studied in
Perimenopausal and postmenopausal women with troublesome hot flushes and night sweats, seeking a non-hormonal botanical option, though trials have not shown a reliable benefit.
Safety
Evidence
Leach & Moore 2012 Cochrane Database Syst Rev meta-analysis (16 RCTs, n=2,027 women): black cohosh did not significantly reduce hot flush frequency versus placebo. The EMA registers it as a traditional herbal medicine for menopausal complaints (long-standing use, not clinical trials). NICE guideline NG23 (2015) notes some evidence of symptom relief but uncertain safety; NICE advises against use in women with breast cancer.
GRADE certainty: Low — rated by Healicus using the GRADE method
- EMA HMPC monograph, Cimicifuga racemosa (L.) Nutt., rhizoma (Traditional Use)
- Leach & Moore, Cochrane Database Syst Rev 2012, black cohosh for menopausal symptoms
- NICE guideline (2015): Menopause: identification and management – NG23
- NICE guideline (2009): Early and locally advanced breast cancer: diagnosis and management – NG101
Questions people ask
Does Black cohosh work?
Leach & Moore 2012 Cochrane Database Syst Rev meta-analysis (16 RCTs, n=2,027 women): black cohosh did not significantly reduce hot flush frequency versus placebo. The EMA registers it as a traditional herbal medicine for menopausal complaints (long-standing use, not clinical trials). NICE guideline NG23 (2015) notes some evidence of symptom relief but uncertain safety; NICE advises against use in women with breast cancer. Certainty of the evidence: Low, rated by Healicus using the GRADE method.
How is Black cohosh taken?
Standardised extracts used in trials: an isopropanolic extract at 40 mg/day, or an ethanolic extract (BNO 1055) at 6.5 mg/day. Higher doses up to 160 mg/day have been used. Timing: Once or twice daily with food. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.
Are there interactions or cautions?
Rare hepatotoxicity reports. Discontinue and seek medical advice for unexplained jaundice, dark urine, or right-upper-quadrant pain. Limit duration to 6 months without medical review. Not for use in pregnancy, breastfeeding, oestrogen-dependent malignancy, or active liver disease. Theoretical interaction with tamoxifen. NICE advises against use in women with breast cancer. Documented drug and supplement interactions can be looked up in the free interaction reference.
What is the evidence based on?
Sources: EMA HMPC monograph, Cimicifuga racemosa (L.) Nutt., rhizoma (Traditional Use); Leach & Moore, Cochrane Database Syst Rev 2012, black cohosh for menopausal symptoms; NICE guideline (2015): Menopause: identification and management – NG23; NICE guideline (2009): Early and locally advanced breast cancer: diagnosis and management – NG101.
One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.